FDA Approves Expansion of BioMarin Pharma Plant

BioMarin Pharmaceutical announced the FDA approved expansion of a manufacturing facility where the company makes several of its drugs and a key experimental drug, according to a San Francisco Chronicle report.

Advertisement

The manufacturing facility, located in Novato, Calif., now has the capacity to produce $1 billion in products — twice its previous capacity.

Related Articles on Supply Chain:
Commentary: Pharmaceutical Companies More Careful About Off-Label Promotion
GE Unveils Discovery IGS 730 Interventional Imaging System at RSNA
FDA Approves Philips’ PET and MRI Whole Body Scanning System

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.